Search
logo
Search
The article is in preview mode

Metabolically healthy obesity

Homepage Articles Metabolically healthy obesity

Metabolically healthy obesity

These side effects include carbohydrate disorders, cardiovascular disease, dyslipidemia, and many, many others. It turns out that there are cases where these complications do not develop. It is widely discussed in the medical community, but it is also often highlighted by body-positive advocates and anti-discrimination activists. More and more people talk about its negative consequences, and yet the percentage of overweight people is increasing every year.

Table of Contents

1. The definition of obesity

Obesity is also divided into two types: transverse (ginoidal) and abdominal (androidal) obesity. In most cases, people with a BMI of more than 30 kg/m2 have elevated blood glucose levels, high cholesterol levels, dyslipidemia or hypertension. These cases are classified as metabolically healthy obesity, and a diagnostic criterion is a BMI that must be at least 30kg/m2. From a metabolic point of view, the latter is much more dangerous and can have a number of health consequences.

2. Is obesity metabolically healthy at all?

Obese metabolically healthy individuals are considered to be those who do not exhibit insulin resistance, hypertension, fatty tissue obesity and have normal fasting glucose levels, respectively high levels of so-called good cholesterol (HDL) and low levels of triglycerides in the blood (R.L. The most important determinant of metabolic disorders in obese people is insulin fat distribution. Stefan, H.-U. Schulze, 2018). Gummesson, P.E. and colleagues also stated in a 2018 study that high blood glucose (high blood cholesterol) levels and low blood sugar (low blood sugar) levels are a direct contributing factor to lower metabolic risk in the body after a full-blooded metabolism study has been conducted. However, it is widely observed that the effects of obesity in men and women are also significantly reduced (see Figure 2 below, Figure 1).

3. Does this even mean that you can be obese and always be healthy?

In fact, people with MHO are less likely to develop type 2 diabetes than obese people with a metabolic syndrome, but the risk is still more than 4 times higher compared to those who are thin (J.A. Kivimaki, M.M. The same is true for women with a risk of developing cardiovascular disease, which is more than 2 times higher than in healthy people (R.C. When it comes to overall mortality, it depends on the number of metabolic disorders that can occur in laboratory studies and are not directly linked to weight loss).

4. They're metabolically obese with the right body mass

Researchers disagree on how to diagnose MONW. However, it is known that at least 2 of the criteria must be met: elevated blood pressure, increased fasting glucose, insulin resistance, waist circumference above 80 cm in women and above 94 cm in men, hyperglyceremia or reduced HDL cholesterol fraction or increased fat tissue content (cutting points vary depending on the study) (K. Pupek-Mlik, P. When describing metabolically healthy people, one cannot fail to mention those who are metabolically obese despite their normal body weight (MON).

5. Can MONW be treated?

When the waist circumference is too large, consideration should be given to weight reduction. It is also worthwhile to focus on folic acid and vitamin B12 and B6 in the diet to avoid increased homocysteine levels, which may be associated with reduced fertility or the development of cardiovascular disease. An integral factor in the treatment of people with MONW is physical activity tailored to the patient's preferences. When lifestyle changes do not produce the expected effects, pharmacotherapy should be considered, of course, in consultation with a physician (N. Due to the fact that people who do not experience the negative effects of MONW on their diet and diet, and it is very difficult to overcome the effects of obesity, obesity and other metabolic diseases such as type 2 diabetes and obesity are considered to be very beneficial for their lives.

Category:
Source

5B81 Obesity (11th ed), WHO, icd.who.int/browse11/l-m/en#/http://id.who.int/icd/entity/149403041 (14.04.2023).
Bell J.A., Kivimaki M., Hamer M., Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies, „Obesity Reviews” 2014, 15(6), 504–515.
Caleyachetty R. et al., Metabolically Healthy Obese and Incident Cardiovascular Disease Events Among 3.5 Million Men and Women, „Journal of the American College of Cardiology” 2017, 70(12), 1429–1437.
Eckel N. et al., Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses’ Health Study): 30 year follow-up from a prospective cohort study, „The Lancet Diabetes & Endocrinology” 2018, 6(9), 714–724.
Ghaben A.L., Scherer P.E., Adipogenesis and metabolic health, „Nature Reviews Molecular Cell Biology” 2019, 20(4), 242–258.
Gummesson A. et al., Non-alcoholic fatty liver disease is a strong predictor of coronary artery calcification in metabolically healthy subjects: A cross-sectional, population-based study in middle-aged subjects, „PLOS One” 2018, 13(8), epub.
Hamer M., Johnson W., Bell J.A., Improving risk estimates for metabolically healthy obesity and mortality using a refined healthy reference group, „European Journal of Endocrinology” 2017, 177(2), 169–174.
Kabat G.C. et al., Metabolic phenotypes of obesity: frequency, correlates and change over time in a cohort of postmenopausal women, „International Journal of Obesity” 2017, 41(1), 170–177.
Kanagasabai Th. et al., Association between Sleep Habits and Metabolically Healthy Obesity in Adults: A Cross-Sectional Study, „Journal of Obesity” 2017, 2017, epub.
Mongraw-Chaffin M. et al., Metabolically Healthy Obesity, Metabolic Syndrome, and Cardiovascular Risk, „Journal of the American College of Cardiology” 2018, 71(17), 1857–1865.
Ortega F.B. et al., Role of Physical Activity and Fitness in the Characterization and Prognosis of the Metabolically Healthy Obesity Phenotype: A Systematic Review and Meta-analysis, „Progress in Cardiovascular Diseases” 2018, 61(2), 190–205.
Pastusiak K., Pupek-Musialik D., Bogdański P., Otyłość metaboliczna z prawidłową masą ciała – kontrowersje w diagnostyce, „Forum Zaburzeń Metabolicznych” 2018, 9(1), 9–15.
Phillips C.M. et al., Defining Metabolically Healthy Obesity: Role of Dietary and Lifestyle Factors, „PLOS One” 2013, 8(10), epub.
Prince R.L. et al., Predictors of Metabolically Healthy Obesity in Children, „Diabetes Care” 2014, 37(5), 1462–1468.
Ruderman N. et al., The metabolically obese, normal-weight individual revisited, „Diabetes” 1998, 47(5), 699–713.
Stefan N., Häring H.-U., Schulze M.B., Metabolically healthy obesity: the low-hanging fruit in obesity treatment?, „The Lancet Diabetes & Endocrinology” 2018, 6(3), 249–258.